This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tetra (TTEK) Up 5.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tetra (TTEK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Avoid Betting on Tetra Tech (TTEK)
by Zacks Equity Research
Tetra Tech (TTEK) has been suffering from a soft demand environment, rising operating costs and several other issues.
Tetra Tech (TTEK) Q2 Earnings Surpass Estimates, Rise Y/Y
by Zacks Equity Research
Tetra Tech's (TTEK) Q2 earnings rise 4.3% year over year on sales growth.
Tetra Tech (TTEK) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Tetra (TTEK) delivered earnings and revenue surprises of 1.39% and -1.63%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Tetra Tech (TTEK) Wins $90M Contract From U.S. Air Force
by Zacks Equity Research
Tetra Tech (TTEK) gains from contracts received from government agencies. The technical support services contract from the U.S. Air Force will likely boost the company's business in Africa and Europe.
Tetra Tech (TTEK) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Tetra (TTEK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CECE vs. TTEK: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CECE vs. TTEK: Which Stock Is the Better Value Option?
Tetra Tech (TTEK) Wins $300M Contract From Federal Client
by Zacks Equity Research
Tetra Tech (TTEK) gains from contracts received from government agencies, including the recent $300 million multiple-award contract from the DoD.
CECE vs. TTEK: Which Stock Is the Better Value Option?
by Zacks Equity Research
CECE vs. TTEK: Which Stock Is the Better Value Option?
Sonoco Rides on Cost Control, Buyouts Amid Coronavirus Fears
by Zacks Equity Research
Sonoco (SON) is well poised to benefit from focus on optimizing businesses and cost control, and acquisitions despite the coronavirus related impact.
Grainger Reduces Credit Facility to Boost Liquidity Position
by Zacks Equity Research
Grainger (GWW) opts to abate $1-billion unsecured revolving credit facility to boost liquidity position amid global economic concerns over the coronavirus outbreak.
Nordson (NDSN) Announces Plan to Reorganize into 2 Businesses
by Zacks Equity Research
Nordson's (NDSN) business realignment will likely help it achieve its long-term priorities. It also intends on bringing its financial reporting on par with the new business structure.
Why Hold Strategy is Apt for Avery Dennison Stock Right Now
by Zacks Equity Research
Given its focus on pricing action, restructuring activities and stellar growth projections, Avery Dennison (AVY) stock is worth retaining in the portfolio at the moment.
Pentair Halts Operations, Pulls Guidance on Coronavirus Scare
by Zacks Equity Research
Pentair (PNR) suspends operations in major facilities and withdraws financial outlook.
AptarGroup (ATR) Hurt by Cost Woes & Coronavirus Outbreak
by Zacks Equity Research
AptarGroup (ATR) expects weaker current-quarter results due to negative impact of the coronavirus pandemic.
iRobot (IRBT) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Due to the pandemic, iRobot (IRBT) lowers sales view for first-quarter 2020 and withdraws annual projections. It expects to witness relief if Roomba products get excluded from Section 301 tariffs.
Enerpac Tool (EPAC) Lags on Q2 Earnings, Discontinues View
by Zacks Equity Research
Enerpac Tool (EPAC) Q2 results reflect weak sales and operating performance. It discontinues the fiscal 2020 projections due to volatility in oil prices and the coronavirus outbreak.
CECE vs. TTEK: Which Stock Is the Better Value Option?
by Zacks Equity Research
CECE vs. TTEK: Which Stock Is the Better Value Option?
Dover (DOV) to Buy Em-tec, Sees Growth in Biopharma Market
by Zacks Equity Research
The latest acquisition will help Dover (DOV) expand its offerings into biopharma and other hygienic applications.
Industrial Production Up M/M in February: 5 Stocks to Buy
by Payal Jalan
Industrial production rises m/m in February on strong manufacturing and utilities sectors. In spite of the rebound, the coronavirus threat remains. Amid this, five stocks might boost your portfolio.
Manitowoc Bets on Cost Control & Innovation Amid Weak Demand
by Zacks Equity Research
Focus on cost controls, increasing productivity and pricing actions are likely to drive the margins for Manitowoc (MTW).
Ball Corp Rides on Solid Beverage-Can Demand Amid FX Woes
by Zacks Equity Research
Ball Corp (BLL) poised to bank on increasing beverage-can demand by investing in capacity and products.
Lindsay Wins Highways England Movable-Barrier Supply Contract
by Zacks Equity Research
Lindsay's (LNN) Road Zipper System solution will enable movable barriers to deploy a quick contraflow for traffic traveling in the opposite direction.
Reasons Why You Should Avoid Donaldson's (DCI) Stock for Now
by Zacks Equity Research
Donaldson (DCI) is exposed to forex woes and soft market conditions. Projections for fiscal 2020 have been lowered on these prevalent headwinds.
Reasons to Hold Crown Holdings Stock in Your Portfolio Now
by Zacks Equity Research
The growing popularity of beverage can as a preferred package for marketers and consumers globally bodes well for Crown Holdings (CCK).